275 related articles for article (PubMed ID: 20163480)
1. Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease.
Devos D; Defebvre L; Bordet R
Fundam Clin Pharmacol; 2010 Aug; 24(4):407-21. PubMed ID: 20163480
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological hypotheses and therapeutic strategies for gait disorders in Parkinson's disease].
Devos D; Bordet R; Defebvre L
Rev Neurol (Paris); 2010 Feb; 166(2):168-77. PubMed ID: 19811797
[TBL] [Abstract][Full Text] [Related]
3. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease.
Ferraye MU; Debû B; Fraix V; Goetz L; Ardouin C; Yelnik J; Henry-Lagrange C; Seigneuret E; Piallat B; Krack P; Le Bas JF; Benabid AL; Chabardès S; Pollak P
Brain; 2010 Jan; 133(Pt 1):205-14. PubMed ID: 19773356
[TBL] [Abstract][Full Text] [Related]
4. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
Yamada K; Goto S; Hamasaki T; Kuratsu JI
Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
[TBL] [Abstract][Full Text] [Related]
5. Deep brain stimulation effects on gait variability in Parkinson's disease.
Hausdorff JM; Gruendlinger L; Scollins L; O'Herron S; Tarsy D
Mov Disord; 2009 Aug; 24(11):1688-92. PubMed ID: 19554569
[TBL] [Abstract][Full Text] [Related]
6. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease.
Moreau C; Defebvre L; Destée A; Bleuse S; Clement F; Blatt JL; Krystkowiak P; Devos D
Neurology; 2008 Jul; 71(2):80-4. PubMed ID: 18420482
[TBL] [Abstract][Full Text] [Related]
7. Outcomes from stimulation of the caudal zona incerta and pedunculopontine nucleus in patients with Parkinson's disease.
Khan S; Mooney L; Plaha P; Javed S; White P; Whone AL; Gill SS
Br J Neurosurg; 2011 Apr; 25(2):273-80. PubMed ID: 21344974
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of the pedunculopontine nucleus area in Parkinson's disease: effects on speech and intelligibility.
Pinto S; Ferraye M; Espesser R; Fraix V; Maillet A; Guirchoum J; Layani-Zemour D; Ghio A; Chabardès S; Pollak P; Debû B
Brain; 2014 Oct; 137(Pt 10):2759-72. PubMed ID: 25080284
[TBL] [Abstract][Full Text] [Related]
9. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
[TBL] [Abstract][Full Text] [Related]
10. [Deep brain stimulation and gait disorders in Parkinson disease].
Ferraye MU; Debû B; Pollak P
Rev Neurol (Paris); 2010 Feb; 166(2):178-87. PubMed ID: 19815246
[TBL] [Abstract][Full Text] [Related]
11. Improvement of hand dexterity induced by stimulation of the peduncolopontine nucleus in a patient with advanced Parkinson's disease and previous long-lasting bilateral subthalamic DBS.
Franzini A; Messina G; Zekaj E; Romito L; Cordella R
Acta Neurochir (Wien); 2011 Aug; 153(8):1587-90. PubMed ID: 21638144
[TBL] [Abstract][Full Text] [Related]
12. New pharmacological options for treating advanced Parkinson's disease.
Devos D; Moreau C; Dujardin K; Cabantchik I; Defebvre L; Bordet R
Clin Ther; 2013 Oct; 35(10):1640-52. PubMed ID: 24011636
[TBL] [Abstract][Full Text] [Related]
13. Pedunculopontine nucleus stimulation for people with Parkinson's disease? A clinical perspective.
Gregory R
Br J Neurosurg; 2008; 22 Suppl 1():S13-5. PubMed ID: 19085347
[TBL] [Abstract][Full Text] [Related]
14. STN versus PPN-DBS for alleviating freezing of gait: toward a frequency modulation approach?
Moreau C; Defebvre L; Devos D; Marchetti F; Destée A; Stefani A; Peppe A
Mov Disord; 2009 Oct; 24(14):2164-6. PubMed ID: 19705483
[No Abstract] [Full Text] [Related]
15. The network of causal interactions for beta oscillations in the pedunculopontine nucleus, primary motor cortex, and subthalamic nucleus of walking parkinsonian rats.
Li M; Zhou M; Wen P; Wang Q; Yang Y; Xiao H; Xie Z; Li X; Wang N; Wang J; Luo F; Chang J; Zhang W
Exp Neurol; 2016 Aug; 282():27-36. PubMed ID: 27163550
[TBL] [Abstract][Full Text] [Related]
16. High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats.
Vlamings R; Visser-Vandewalle V; Koopmans G; Joosten EA; Kozan R; Kaplan S; Steinbusch HW; Temel Y
Neuroscience; 2007 Sep; 148(3):815-23. PubMed ID: 17706885
[TBL] [Abstract][Full Text] [Related]
17. Deep brain stimulation of the pedunculopontine tegmentum and subthalamic nucleus: effects on gait in Parkinson's disease.
Peppe A; Pierantozzi M; Chiavalon C; Marchetti F; Caltagirone C; Musicco M; Stanzione P; Stefani A
Gait Posture; 2010 Oct; 32(4):512-8. PubMed ID: 20727761
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication.
Rolland AS; Tandé D; Herrero MT; Luquin MR; Vazquez-Claverie M; Karachi C; Hirsch EC; François C
J Neurochem; 2009 Aug; 110(4):1321-9. PubMed ID: 19527435
[TBL] [Abstract][Full Text] [Related]
19. Role of deep brain stimulation targeted to the pedunculopontine nucleus in Parkinson's disease.
Kenney C; Fernandez HH; Okun MS
Expert Rev Neurother; 2007 Jun; 7(6):585-9. PubMed ID: 17563240
[No Abstract] [Full Text] [Related]
20. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
